Targeting TNF-alpha: a novel therapeutic approach for asthma.

PubWeight™: 1.80‹?› | Rank: Top 3%

🔗 View Article (PMC 3992375)

Published in J Allergy Clin Immunol on November 26, 2007

Authors

Christopher Brightling1, Mike Berry, Yassine Amrani

Author Affiliations

1: Institute of Lung Health, University of Leicester, Leicester, United Kingdom. ceb17@le.ac.uk

Articles citing this

Biological clustering supports both "Dutch" and "British" hypotheses of asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol (2014) 1.43

MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets. PLoS One (2011) 1.31

Treatment of allergic asthma: modulation of Th2 cells and their responses. Respir Res (2011) 1.31

Adoptive transfer of IL-4Rα+ macrophages is sufficient to enhance eosinophilic inflammation in a mouse model of allergic lung inflammation. BMC Immunol (2012) 1.21

Tissue remodeling in eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol (2012) 1.20

Obesity enhances eosinophilic inflammation in a murine model of allergic asthma. Br J Pharmacol (2010) 1.18

Pulmonary complications of tumor necrosis factor-targeted therapy. Respir Med (2009) 1.11

Neurotrophins in lung health and disease. Expert Rev Respir Med (2010) 1.05

Double-stranded RNA induces shedding of the 34-kDa soluble TNFR1 from human airway epithelial cells via TLR3-TRIF-RIP1-dependent signaling: roles for dual oxidase 2- and caspase-dependent pathways. J Immunol (2010) 1.04

Insulin-like growth factor-binding protein-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-κB signaling through IGFBP-3R-mediated activation of caspases. J Biol Chem (2011) 0.98

Tumour necrosis factor-α regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NF-κB and AP-1. PLoS One (2014) 0.97

Calcium transient evoked by TRPV1 activators is enhanced by tumor necrosis factor-{alpha} in rat pulmonary sensory neurons. Am J Physiol Lung Cell Mol Physiol (2010) 0.97

The link between allergies and eosinophilic esophagitis: implications for management strategies. Expert Rev Clin Immunol (2010) 0.95

The complex relationship between inflammation and lung function in severe asthma. Mucosal Immunol (2014) 0.93

Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice. PLoS One (2013) 0.92

Update on anticytokine treatment for asthma. Biomed Res Int (2013) 0.92

Influenza enhances caspase-1 in bronchial epithelial cells from asthmatic volunteers and is associated with pathogenesis. J Allergy Clin Immunol (2012) 0.91

Proinflammatory and Th2 cytokines regulate the high affinity IgE receptor (FcepsilonRI) and IgE-dependant activation of human airway smooth muscle cells. PLoS One (2009) 0.91

Attenuation of antigen-induced airway hyperresponsiveness and inflammation in CXCR3 knockout mice. Respir Res (2011) 0.89

Dietary long-chain omega-3 fatty acids do not diminish eosinophilic pulmonary inflammation in mice. Am J Respir Cell Mol Biol (2014) 0.89

Toll-like receptor expression on peripheral blood mononuclear cells in asthmatics; implications for asthma management. J Clin Immunol (2010) 0.89

Alveolar macrophages play a key role in cockroach-induced allergic inflammation via TNF-α pathway. PLoS One (2012) 0.87

Sputum IgE and cytokines in asthma: relationship with sputum cellular profile. PLoS One (2013) 0.87

Does airway smooth muscle express an inflammatory phenotype in asthma? Br J Pharmacol (2011) 0.86

Monoclonal Anti-TNF-α Antibodies for Severe Steroid-Dependent Asthma: A Case Series. Open Respir Med J (2013) 0.86

Pulmonary chemoreflex responses are potentiated by tumor necrosis factor-alpha in mice. J Appl Physiol (1985) (2013) 0.85

25-Hydroxyvitamin D3-deficiency enhances oxidative stress and corticosteroid resistance in severe asthma exacerbation. PLoS One (2014) 0.85

Monoclonal antibodies and other biologic agents in the treatment of asthma. MAbs (2009) 0.85

Cytokine and anti-cytokine therapy in asthma: ready for the clinic? Clin Exp Immunol (2009) 0.85

Molecular Mechanisms of Airway Hyperresponsiveness in a Murine Model of Steroid-Resistant Airway Inflammation. J Immunol (2016) 0.85

The other T helper cells in asthma pathogenesis. J Allergy (Cairo) (2010) 0.84

Drug development for severe asthma: what are the metrics? Pharmacol Ther (2012) 0.84

New roles for mast cells in modulating allergic reactions and immunity against pathogens. Curr Opin Immunol (2009) 0.83

Effect of Antiasthma Simplified Herbal Medicine Intervention on neutrophil predominant airway inflammation in a ragweed sensitized murine asthma model. Ann Allergy Asthma Immunol (2014) 0.83

Asthma and dehydroepiandrosterone (DHEA): facts and hypotheses. Inflammation (2010) 0.82

Ganoderic acid C1 isolated from the anti-asthma formula, ASHMI™ suppresses TNF-α production by mouse macrophages and peripheral blood mononuclear cells from asthma patients. Int Immunopharmacol (2015) 0.81

Deficiency in the serum-derived hyaluronan-associated protein-hyaluronan complex enhances airway hyperresponsiveness in a murine model of asthma. Int Arch Allergy Immunol (2010) 0.81

The tyrosine kinase inhibitor dasatinib reduces lung inflammation and remodelling in experimental allergic asthma. Br J Pharmacol (2016) 0.81

Effect of prostaglandin I2 analogs on cytokine expression in human myeloid dendritic cells via epigenetic regulation. Mol Med (2012) 0.81

Activation of EP4 receptors prevents endotoxin-induced neutrophil infiltration into the airways and enhances microvascular barrier function. Br J Pharmacol (2015) 0.80

FastGGM: An Efficient Algorithm for the Inference of Gaussian Graphical Model in Biological Networks. PLoS Comput Biol (2016) 0.80

miRNA-221-3p Enhances the Secretion of Interleukin-4 in Mast Cells through the Phosphatase and Tensin Homolog/p38/Nuclear Factor-kappaB Pathway. PLoS One (2016) 0.79

Epidermal growth factor receptor signalling regulates granulocyte-macrophage colony-stimulating factor production by airway epithelial cells and established allergic airway disease. Clin Exp Allergy (2016) 0.79

MAG-EPA and 17,18-EpETE target cytoplasmic signalling pathways to reduce short-term airway hyperresponsiveness. Pflugers Arch (2014) 0.79

Mast cells in airway diseases and interstitial lung disease. Eur J Pharmacol (2015) 0.79

Protective effect of naringenin against lipopolysaccharide-induced injury in normal human bronchial epithelium via suppression of MAPK signaling. Inflammation (2015) 0.78

Obesity increases airway hyperresponsiveness via the TNF-α pathway and treating obesity induces recovery. PLoS One (2015) 0.77

Antagonism of cytokine-induced eosinophil accumulation in asthma. Front Pharmacol (2012) 0.77

Asthma therapies revisited: what have we learned? Proc Am Thorac Soc (2009) 0.77

Protein phosphatase 5 mediates corticosteroid insensitivity in airway smooth muscle in patients with severe asthma. Allergy (2016) 0.76

TNF-α-induces airway hyperresponsiveness to cholinergic stimulation in guinea pig airways. Br J Pharmacol (2012) 0.76

Phellinus linteus Extract Exerts Anti-asthmatic Effects by Suppressing NF-κB and p38 MAPK Activity in an OVA-induced Mouse Model of Asthma. Immune Netw (2014) 0.76

TNF up-regulates Pentraxin3 expression in human airway smooth muscle cells via JNK and ERK1/2 MAPK pathways. Allergy Asthma Clin Immunol (2015) 0.76

Antigen-induced airway hyperresponsiveness and obstruction is related to caveolin-1 expression in airway smooth muscle in a guinea pig asthma model. Clin Transl Allergy (2015) 0.76

Changes of serum TNF-α, IL-5 and IgE levels in the patients of mycoplasma pneumonia infection with or without bronchial asthma. Int J Clin Exp Med (2015) 0.75

Shared genetic variants between serum levels of high-density lipoprotein cholesterol and wheezing in a cohort of children from Cyprus. Ital J Pediatr (2016) 0.75

Effect of mouse strain in a model of chemical-induced respiratory allergy. Exp Anim (2014) 0.75

Ribosomal Protein S3 Gene Silencing Protects Against Experimental Allergic Asthma. Br J Pharmacol (2017) 0.75

Sputum Inflammatory Mediators Are Increased in Aspergillus fumigatus Culture-Positive Asthmatics. Allergy Asthma Immunol Res (2017) 0.75

Biomarkers in the Management of Difficult Asthma. Curr Top Med Chem (2016) 0.75

MAG-DPA curbs inflammatory biomarkers and pharmacological reactivity in cytokine-triggered hyperresponsive airway models. Pharmacol Res Perspect (2016) 0.75

Effect of cholesterol depletion on interleukin-8 production in human respiratory epithelial cells. Allergy Asthma Immunol Res (2013) 0.75

Mometasone Furoate Suppresses PMA-Induced MUC-5AC and MUC-2 Production in Human Airway Epithelial Cells. Tuberc Respir Dis (Seoul) (2016) 0.75

M2 Muscarinic acetylcholine receptor modulates rat airway smooth muscle cell proliferation. World Allergy Organ J (2013) 0.75

PKCα signaling pathway involves in TNF-α-induced IP3R1 expression in human mesangial cells. World J Emerg Med (2012) 0.75

Hypersensitivity of Vagal Pulmonary Afferents Induced by Tumor Necrosis Factor Alpha in Mice. Front Physiol (2017) 0.75

Aerosolized polymerized type I collagen reduces airway inflammation and remodelling in a guinea pig model of allergic asthma. Lung (2009) 0.75

Sustained sensitizing effects of tumor necrosis factor alpha on sensory nerves in lung and airways. Pulm Pharmacol Ther (2017) 0.75

Newly Divided Eosinophils Limit Ozone-Induced Airway Hyperreactivity In Non-Sensitized Guinea Pigs. Am J Physiol Lung Cell Mol Physiol (2017) 0.75

Articles cited by this

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA (2006) 15.65

Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol (1993) 8.36

Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med (2000) 8.09

Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med (2001) 7.41

Innate immunity. N Engl J Med (2000) 7.03

Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med (2002) 6.52

The global burden of asthma. Chest (2006) 5.74

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell (1988) 5.42

Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med (2006) 4.83

Asthma: defining of the persistent adult phenotypes. Lancet (2006) 4.78

New drugs for rheumatoid arthritis. N Engl J Med (2004) 4.38

Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med (1999) 3.84

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci U S A (1990) 3.59

Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. J Immunol (1987) 3.41

Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol (1994) 2.73

Retracted The effects of a monoclonal antibody directed against tumor necrosis factor-alpha in asthma. Am J Respir Crit Care Med (2006) 2.72

Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax (2005) 2.19

Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J Clin Invest (2002) 2.06

The public health implications of asthma. Bull World Health Organ (2005) 2.04

The active form of tumor necrosis factor is a trimer. J Biol Chem (1987) 1.86

Severe asthma in adults: what are the important questions? J Allergy Clin Immunol (2007) 1.85

Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med (1995) 1.84

Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax (2003) 1.75

TNF-alpha mediates recruitment of neutrophils and eosinophils during airway inflammation. J Immunol (1995) 1.70

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.70

Bronchial inflammation and airway responses to deep inspiration in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.68

CD38/cyclic ADP-ribose-mediated Ca2+ signaling contributes to airway smooth muscle hyper-responsiveness. FASEB J (2003) 1.63

Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J Exp Med (1990) 1.48

Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J (2002) 1.45

Severe asthma: an overview. J Allergy Clin Immunol (2006) 1.44

Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis. FASEB J (2003) 1.44

Evaluation of the contribution of different ADAMs to tumor necrosis factor alpha (TNFalpha) shedding and of the function of the TNFalpha ectodomain in ensuring selective stimulated shedding by the TNFalpha convertase (TACE/ADAM17). J Biol Chem (2004) 1.37

Tumor necrosis factor-alpha induces transforming growth factor-beta1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. Am J Respir Cell Mol Biol (2005) 1.36

Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines. Chest (2006) 1.35

Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab (1999) 1.25

CD38/cyclic ADP-ribose signaling: role in the regulation of calcium homeostasis in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol (2005) 1.23

TNF alpha mRNA expression in allergic inflammation. Clin Exp Allergy (1991) 1.17

TNF-[alpha] modulates murine tracheal rings responsiveness to G-protein-coupled receptor agonists and KCl. J Appl Physiol (1985) (2003) 1.16

The reclassification of asthma based on subphenotypes. Curr Opin Allergy Clin Immunol (2007) 1.14

Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma. Thorax (2002) 1.14

Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta. J Biol Chem (2003) 1.13

Tumor necrosis factor-alpha-induced activation of RhoA in airway smooth muscle cells: role in the Ca2+ sensitization of myosin light chain20 phosphorylation. Mol Pharmacol (2003) 1.12

Modulation of calcium homeostasis as a mechanism for altering smooth muscle responsiveness in asthma. Curr Opin Allergy Clin Immunol (2002) 1.11

Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells. Am J Respir Cell Mol Biol (1996) 1.09

Tumor necrosis factor-alpha differentially regulates the expression of proinflammatory genes in human airway smooth muscle cells by activation of interferon-beta-dependent CD38 pathway. Mol Pharmacol (2004) 1.05

An assay to evaluate the long-term effects of inflammatory mediators on murine airway smooth muscle: evidence that TNFalpha up-regulates 5-HT(2A)-mediated contraction. Br J Pharmacol (2002) 1.01

The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthma. Allergy (2005) 0.97

Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation. Respir Med (2005) 0.96

Anti-TNF-alpha and Th1 cytokine-directed therapies for the treatment of asthma. Curr Opin Allergy Clin Immunol (2006) 0.95

Tumor necrosis factor alpha stimulates leukotriene production in vivo. Eur J Immunol (1988) 0.93

Induction of human airway hyperresponsiveness by tumour necrosis factor-alpha. Eur J Pharmacol (1995) 0.93

Tumour necrosis factor-alpha potentiates contraction of human bronchus in vitro. Respirology (2001) 0.92

Cytokines enhance airway smooth muscle contractility in response to acetylcholine and neurokinin A. Respirology (2000) 0.92

Up-regulation of bradykinin receptors in a murine in-vitro model of chronic airway inflammation. Eur J Pharmacol (2004) 0.92

Tumour necrosis factor-alpha induces hyperreactivity in tracheal smooth muscle of the guinea-pig in vitro. Eur Respir J (1998) 0.90

Tumor necrosis factor alpha potentiates the increase in cytosolic free calcium induced by bradykinin in guinea-pig tracheal smooth muscle cells. C R Acad Sci III (1993) 0.88

Airway remodeling: a comparison between fatal and nonfatal asthma. J Asthma (2004) 0.87

Airway smooth muscle modulation and airway hyper-responsiveness in asthma: new cellular and molecular paradigms. Expert Rev Clin Immunol (2006) 0.86

Potential implication of endothelial cells in bronchial asthma. Int Arch Allergy Appl Immunol (1991) 0.80

Articles by these authors

Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact. FASEB J (2005) 2.13

TGF-beta potentiates airway smooth muscle responsiveness to bradykinin. Am J Physiol Lung Cell Mol Physiol (2005) 1.51

Modulation of calcium signaling by interleukin-13 in human airway smooth muscle: role of CD38/cyclic adenosine diphosphate ribose pathway. Am J Respir Cell Mol Biol (2004) 1.43

Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Am J Respir Cell Mol Biol (2002) 1.37

Sphingosine-1-phosphate stimulates contraction of human airway smooth muscle cells. FASEB J (2003) 1.36

IL-13 enhances agonist-evoked calcium signals and contractile responses in airway smooth muscle. Br J Pharmacol (2003) 1.35

CD38 expression is insensitive to steroid action in cells treated with tumor necrosis factor-alpha and interferon-gamma by a mechanism involving the up-regulation of the glucocorticoid receptor beta isoform. Mol Pharmacol (2005) 1.19

Mechanisms of inflammation-mediated airway smooth muscle plasticity and airways remodeling in asthma. Respir Physiol Neurobiol (2003) 1.17

TNF-[alpha] modulates murine tracheal rings responsiveness to G-protein-coupled receptor agonists and KCl. J Appl Physiol (1985) (2003) 1.16

Cytokines induce an early steroid resistance in airway smooth muscle cells: novel role of interferon regulatory factor-1. Am J Respir Cell Mol Biol (2007) 1.16

Tumor necrosis factor alpha modulates airway smooth muscle function via the autocrine action of interferon beta. J Biol Chem (2003) 1.13

Dietary flaxseed supplementation ameliorates inflammation and oxidative tissue damage in experimental models of acute lung injury in mice. J Nutr (2006) 1.10

Synthetic responses in airway smooth muscle. J Allergy Clin Immunol (2004) 1.09

Oxygen dose responsiveness of human fetal airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol (2012) 1.07

Tumor necrosis factor-alpha differentially regulates the expression of proinflammatory genes in human airway smooth muscle cells by activation of interferon-beta-dependent CD38 pathway. Mol Pharmacol (2004) 1.05

Transcriptional regulation of CD38 expression by tumor necrosis factor-alpha in human airway smooth muscle cells: role of NF-kappaB and sensitivity to glucocorticoids. FASEB J (2006) 1.03

Essential role of IFNbeta and CD38 in TNFalpha-induced airway smooth muscle hyper-responsiveness. Immunobiology (2008) 1.01

Inhibition of tumor necrosis factor-alpha-inducible inflammatory genes by interferon-gamma is associated with altered nuclear factor-kappaB transactivation and enhanced histone deacetylase activity. Mol Pharmacol (2006) 1.01

Social stress enhances allergen-induced airway inflammation in mice and inhibits corticosteroid responsiveness of cytokine production. J Immunol (2009) 1.00

Glucocorticoid receptor interacting protein-1 restores glucocorticoid responsiveness in steroid-resistant airway structural cells. Am J Respir Cell Mol Biol (2009) 0.97

Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis. Mol Pharmacol (2009) 0.95

Vascular endothelial growth factor-induced secretion of fibronectin is ERK dependent. Am J Physiol Lung Cell Mol Physiol (2003) 0.94

Cytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatases. Am J Respir Cell Mol Biol (2012) 0.94

Bradykinin induces interleukin-6 production in human airway smooth muscle cells: modulation by Th2 cytokines and dexamethasone. Am J Respir Cell Mol Biol (2003) 0.91

The effect of IL-13 and IL-13R130Q, a naturally occurring IL-13 polymorphism, on the gene expression of human airway smooth muscle cells. Respir Res (2005) 0.89

Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF. Rheumatology (Oxford) (2013) 0.86

Airway smooth muscle cell as an inflammatory cell: lessons learned from interferon signaling pathways. Proc Am Thorac Soc (2008) 0.86

Chemokine concentrations and mast cell chemotactic activity in BAL fluid in patients with eosinophilic bronchitis and asthma, and in normal control subjects. Chest (2006) 0.86

Interferon beta augments tuberous sclerosis complex 2 (TSC2)-dependent inhibition of TSC2-null ELT3 and human lymphangioleiomyomatosis-derived cell proliferation. Mol Pharmacol (2007) 0.86

Is airway smooth muscle the "missing link" modulating airway inflammation in asthma? Chest (2008) 0.86

Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent. Respir Res (2014) 0.86

TNF-alpha and calcium signaling in airway smooth muscle cells: a never-ending story with promising therapeutic relevance. Am J Respir Cell Mol Biol (2007) 0.85

An RGS4-mediated phenotypic switch of bronchial smooth muscle cells promotes fixed airway obstruction in asthma. PLoS One (2012) 0.84

Vitamin D attenuates cytokine-induced remodeling in human fetal airway smooth muscle cells. J Cell Physiol (2015) 0.84

A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma. Prim Care Respir J (2012) 0.84

Treatment approaches for dual diagnosis clients in England. Drug Alcohol Rev (2008) 0.83

Immunopathogenesis of severe asthma. Curr Pharm Des (2011) 0.82

Tumor necrosis factor-alpha: a promising therapeutic target for asthma? BioDrugs (2007) 0.82

Basal p38 mitogen-activated protein kinase regulates unliganded glucocorticoid receptor function in airway smooth muscle cells. Am J Respir Cell Mol Biol (2014) 0.81

Eosinophilic bronchitis: clinical features, management and pathogenesis. Am J Respir Med (2003) 0.81

Gene expression profiling of flaxseed in mouse lung tissues-modulation of toxicologically relevant genes. BMC Complement Altern Med (2012) 0.80

Counterregulation of beta(2)-adrenoceptor function in human mast cells by stem cell factor. J Allergy Clin Immunol (2009) 0.79

G-protein-coupled receptor agonists differentially regulate basal or tumor necrosis factor-alpha-stimulated activation of interleukin-6 and RANTES in human airway smooth muscle cells. J Biomed Sci (2005) 0.78

Response to C3a, mast cells, and asthma. FASEB J (2006) 0.77

Smooth muscle hypercontractility in airway hyperresponsiveness: innate, acquired, or nonexistent? J Allergy (Cairo) (2013) 0.75